baber/WOPTO huggingface dataset:
Patent NZ-322280-A (NZ)
Title: High performance liquid chromatography method and apparatus
Inventor: QUINN HUBERT M
IPC: B01D15/08
Filed: 1996-11-01
Abstract: A method of and apparatus for liquid chromatography at improved analytical and preparative speeds and quantities involves flow of fluids through the column at flow rates sufficient to induce turbulent flow in those fluids. In one embodiment, the apparatus and method includes a substantially uniform chromatography column created by packing together a multiplicity of rigid, solid, porous particles having diameters of not less than about 30  mu m, surfaces of the particles being chromatographically active. A fluid mixture containing at least one solute that is reactive with the particle surfaces is injected into the column and subsequently eluted therefrom by a eluant fluid flow, both the injection and elution being effected at a velocity sufficient to induce flow within at least a substantial portion of the interstitial volume between the particles at a reduced velocity greater than about 5,000.
Patent NZ-333248-A (NZ)
Title: Process for producing a catalyst for the preparation of vinyl acetate in the gas phase, the catalyst comprising palladium, gold and an alkali metal
Inventor: HERZOG BERNHARD
IPC: C07B61/00
Filed: 1998-12-09
Abstract: The process is for the preparation of a catalyst on a particulate porous support.  The catalyst is used in the preparation of vinyl acetate in the gas phase from ethylene, acetic acid and oxygen or oxygen-containing gases.  The process comprises: a) impregnating the support with soluble palladium and gold compounds; b) converting the soluble palladium and gold compounds into insoluble compounds by the addition of an alkaline solution; c) reducing the insoluble compounds by means of a reducing agent in liquid or gaseous phase; d) impregnating the support with at least one soluble alkali metal compound; and e) finally drying the support at a maximum temperature of 150 degrees C. The catalyst is irradiated with microwaves before, during or after any of steps a) to e).
Patent NZ-336319-A (NZ)
Title: Pharmaceutical composition for non-colloidal iron (ferric) delivery in hemodialysis and peritoneal dialysis patients
Inventor: GUPTA AJAY
IPC: A61K33/26
Filed: 1997-12-30
Abstract: A method of administering iron to dialysis patients is accomplished by infusion of a non-colloidal ferric compound, soluble in hemodialysis or peritoneal dialysis solutions, by the process of dialysis. A pharmaceutical composition is provided consisting essentially of dialysis solution including a soluble non-colloidal ferric compound, preferably ferric pyrophosphate.
Patent NZ-337141-A (NZ)
Title: Adjustable partitions for cargo space of a vehicle
Inventor: RUSSELL REX H
IPC: B60R7/02
Filed: 1999-08-10
Abstract: A storage divider for a vehicle luggage or freight compartment includes a rail 2 attached  to the floor of the compartment.  A partition 4 is attached to the rail, so that the partition can slide along the rail.  The partition can be locked to the rail.  A second partition 6 is hinged to the partition 4 to further subdivide the luggage space.  The partition 6 can fold up flat against the partition 4, which in turn can be folded flat against the floor.  The rail can be detached from the floor when the divider is not required.  There may be two rails 2; and a third partition may be hinged to the partition 6.
Patent NZ-337181-A (NZ)
Title: Pet food composition containing fermentable fibres containing beet pulp
Inventor: REINHART GREGORY ALLEN
IPC: A23K1/18
Filed: 1998-02-16
Abstract: The pet food product contains fermentable fibers being a blend of: a) beet pulp, gum talha and fructooligosaccharides or b) beet pulp, gum arabic and fructooligosaccharides. The fermentable fibers are present in amounts from 1 to 11 weight percent of supplemental total dietary fiber and have an organic matter disappearance of 15 to 60 percent when fermented by fecal bacteria for a 24 hour period.
Patent NZ-337411-A (NZ)
Title: Bagpipe reed comprising a tubular body
Inventor: WYGENT MARK A
IPC: G10D9/02
Filed: 1999-08-24
Abstract: This particular design for providing a substitute to a cane bagpipe reed incorporates a wood-based, polymer body (the tube), two thin plastic tongues, regulated by a short length of synthetic tubing (the bridle). A brass or plastic tube is screwed or pressed in one end to form the "seat" of the reed, or that portion which is pressed into the bagpipe itself. An opposite end of the tubular body includes a tuning pin to change a pitch of the reed. The bagpipe reed is fashioned from a hollow tube as a body, threaded or tapered at both ends to provide for the use of a threaded or tapered plug (tuning pin) at either end, employed to adjust airflow and pitch. The tuning pin is a socket headed cap screw having external threads at one end and an enlarged, knurled head at the opposite end. The head includes a hexagonal shaped opening for rotation of the tuning pin into and out of the tubular body by an allen wrench. The opposite end of the tubular body includes a threaded and tapered reed seat or moveable insertion base for the reed. The reed seat may be externally threaded at one end and include wrapped waxed threads in a tapered, conical configuration at the opposite end. The reed seat is moulded to include a plurality of ridges to assist in gripping waxed thread wrapped around the reed seat.
Patent NZ-508796-A (NZ)
Title: A card game, typically of blackjack form, with further betting zone(s) for pre-nominated or paramount winning hand for participants to place bets on
Inventor: MANOV ATANAS VISSILEV
IPC: A47B25/00
Filed: 1999-05-12
Abstract: A casino card game having a substantially semi-circle shaped card game surface (10) is provided for participants to selectively place bets on a player hand winning zone (20), player having Blackjack zone (18), the dealer hand winning zone (24), the dealer having Blackjack zone (22), and a tie betting zone (26). The surface (10) has seven sectors (16) and the above betting zones (18 to 26) are arranged in each of the sectors (16). Cards are dealt to only the player hand (28) and the dealer hand (30) positioned on the surface (10). A bet on a player hand winning zone (20) or a dealer hand winning zone (26) is a winner when the player hand (28) or the dealer hand (30) wins. A bet on a player Blackjack zone (18) or the dealer Blackjack zone (22) is a winner only when the player hand (28) or the dealer hand (30) has a Blackjack hand. A tie hand is declared when the cumulative card values of the player hand (28) and the dealer hand (30) are the same whether they are bust (exceeding 21) or not. A winning hand is declared when a hand has a cumulative card value of 17 or more and is closer to 21 than the other hand, or has a Blackjack hand and the other hand does not have a Blackjack hand. Winning bets are paid according to the odds allocated for the betting zones (18 to 26).
Patent NZ-509251-A (NZ)
Title: Collapsible containers with four side panels releasably coupled to respective sides of a four sided base
Inventor: KARPISEK LADISLAV STEPHAN
IPC: B65D19/12
Filed: 1999-07-07
Abstract: A container comprising a base (2) and four side panels (6, 7, 8, 9), a pair of opposed side panels (6, 8) are coupled to upstanding corner posts (10) of the base (2) and the other pair of panels (7, 9) are coupled to rails (5) upstanding from the base (2), the couplings normally allow the panels to be moved between upstanding condition where the panels are interlocked with each other and are held by retainers (12) to the base (2) and the rails (5), and storage condition where the panels lie one over the other over the base. The couplings are through panel mounted track followers engaged in "L" shaped tracks (17, 19) in the corner posts (10) and the rails (5) respectively. First limbs of the "L" shaped tracks (17, 19) are open ended allowing sequential demounting of the panels (6, 8 and 7, 9) form the base (2) by passage of the track followers through the open ends of the tracks (17, 19). Demounting of the panels (7, 9) coupled to the rails (5) is normally prevented until the panels (6, 8) coupled to the posts (10) have been demounted form the base (2).
Patent NZ-509415-A (NZ)
Title: Paint and paper coated with said paint
Inventor: WILCKE MICHAEL
IPC: C09D5/02
Filed: 1999-07-21
Abstract: A spreadable paint containing a pigment mixture, an adhesive as well as water and known coating aids, wherein the pigment mixture is composed of precipitated silicic acid with a specific surface area of 600 m2/g to 700 m2/g and an absorber pigment which absorbs excitation radiation from the ultraviolet or visible region of the spectrum is disclosed. A coated paper (1) coated with a coat made from one of these spreadable paints as shown in figures 1 and 2 is also disclosed, whose paper carrier (2) contains a paper dye which emits fluorescence as a result of being irradiated with an excitation radiation, which itself is at least partially absorbed by an absorber pigment of the coating. The coating (3) according to the invention preferably absorbs UV light and has the characteristic that large areas detach from the paper carrier (2) due to mechanical tampering attempts such as scratching or erasure so that forged forms are rendered recognizable with the help of, for example, optical whiteners in the paper carrier (2).
Patent NZ-509677-A (NZ)
Title: Laser cutting and joining a fluorinated polymer membrane to a polymer frame
Inventor: WILLIAMS PAUL EDWARD
IPC: B23K26/40
Filed: 1999-07-20
Abstract: Method and apparatus for cutting a fluorinated polymer membrane and simultaneously joining it to a polymer frame. The method comprising the steps of: (i) contacting a fluorinated polymer membrane with a polymer frame at the point where a cut and join is desired, and (ii) directing at least one laser beam onto the point of contact between the membrane and the frame so as to cut the membrane and effect a join to the frame.
Patent NZ-514481-A (NZ)
Title: Vacuum assisted closure system with provision for introduction of agent
Inventor: JOHNSON ROYCE W
IPC: A61L2/16
Filed: 2000-03-31
Abstract: A method, and apparatus for the introduction to a wound under vacuum assisted closure (VAC) therapy of a wound healing agent, generally comprises a foam pad (11) for insertion substantially into a wound site (12), and a wound drape (13) for sealing enclosure of the foam pad at the wound site. The foam pad is placed in fluid communication with a vacuum source for promotion of fluid drainage. Additionally, the foam pad is predisposed, through grafting or other techniques known to those of ordinary skill in the art, with basic fibroblast growth factor (bFGF), anti-microbial or other factors, also known to those of ordinary skill in the art, for the promotion of increased wound healing.
Patent NZ-519459-A (NZ)
Title: Isoindoline derivatives useful for treating a disease mediated by TNFalpha or phosphodiesterase
Inventor: MAN HON-WAH
IPC: C07D209/48
Filed: 2000-11-09
Abstract: Isoindolin-1-one and Isoindoline-1, 3-dione substituted in the 2-position with an alpha -(3, 4-disubstituted phenyl)alkyl group and in the 4- and/or 5-position with a nitrogen-containing group are inhibitors of, and thus useful in the treatment of disease states mediated by, TNF alpha and phosphodiesterase. A typical embodiment is 2-[1- (3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4,5- diaminoisoindoline-1,3-dione.
Patent NZ-522601-A (NZ)
Title: Building   block   of  stepped   configuration   with interengaging ridges and grooves
Inventor: VAN DEN BERG DANIEL COENRAAD
IPC: E04B2/08
Filed: 2002-11-14
Abstract: Blocks   11   are   of  stepped  configuration   with complementary  ribs  5  to engage  recesses  6  on  adjacent blocks. Upper and lower blocks are L-shaped to complete  the construction. Various embodiments are disclosed.
Patent NZ-532780-A (NZ)
Title: Isolated naturally occurring mutant human B-Raf polypeptides and nucleic acids encoding them
Inventor: STRATTON MIKE
IPC: C12Q1/68
Filed: 2002-12-23
Abstract: Disclosed is an isolated naturally-occurring mutant human B-Raf polypeptide comprising one or more amino acid mutations, wherein the single amino acid mutations are located C-terminal to amino acid 300 in B-Raf, and wherein the amino acid mutations occur at one or more of positions 463, 465, 468, 585, 594, 595, 596 and 599 in B-Raf. Also disclosed are complements of nucleic acids encoding said mutant human B-Raf polypeptide, ligands binding selectively to said polypeptide and methods of detecting said mutations. Mutations in the sites disclosed are shown to have an oncogenic effects and inhibitory effects on kinases.
Patent NZ-532864-A (NZ)
Title: Benzimidazol- or indol-aminoacetonitrile derivatives for parasite control
Inventor: DUCRAY PIERRE
IPC: C07D209/30
Filed: 2002-11-13
Abstract: Disclosed are compounds of the formula (I); wherein, R3 R4 and R5 either, independently of one another, signify hydrogen, halogen, C1-C6-alkyl, halo- C1-C6-alkyl, C3-C6-cycloalkyl that is either unsubstituted or substituted once or many times, whereby the substituents may be independent of one another and are selected from the group consisting of halogen and C1-C6-alkyl; phenyl that is either unsubstituted or substituted once or many times, whereby the substituents may be independent of one another and are selected from the group consisting of halogen, nitro, cyano, C1-C6-alkyl, halo- C1-C6-alkyl, C1-C6-alkoxy, halo- C1-C6-alkoxy, C1-C6-alkoxy, C1-C6-alkylthio, halo C1-C6-alkylthio, C1-C6-alkylsulfinyl, halo- C1-C6-alkylsulfinyl, C1-C6-alkylsulfonyl, halo-C1-C6-sulfonyl, C1-C6-alkylamino or di-( C1-C6-alkyl)amino; or R4 and R5 together signify C2-C6-alkylene; X signifies C(R10) or N; Y signifies a direct bond, C(O), C(S), or S(O)n; a signifies 1, 2 or 3; n is 0, 1 or 2; and the other substituents are defined in the specification. Further disclosed are processes for their preparation and their use in the control of parasites on warm blooded animals excluding humans.
Patent NZ-532968-A (NZ)
Title: Drug delivery system for conscious sedation
Inventor: BURNS WILLIAM H
IPC: A61M31/00
Filed: 2002-10-17
Abstract: Disclosed herein is a system for delivery of a mixture of gases to a patient effective to produce analgesia in a patient wherein the system comprises: (a) means for forming a mixture of oxygen and halogenated ether by mixing oxygen with halogenated ether; (b) means for controlling the proportions of oxygen and halogenated ether in the mixture such that the mixture comprises a ratio of oxygen to halogentated ether effective for producing analgesia without loss of consciousness in a patient; and (c) means for delivering said mixture to said patient.
Patent NZ-533787-A (NZ)
Title: Detecting and measuring interference contained within a digital carrier
Inventor: CHU JEFFREY C
IPC: H04L1/20
Filed: 2003-02-26
Abstract: A method of detecting in-band interference in a carrier signal in a communication system is disclosed which includes the steps of (a) acquiring a digital signal which includes receiving the signal, filtering the signal, digitizing the filtered signal and converting the carrier signal into an IF signal representative of the carrier signal, (b) formatting the digital signal where the formatting includes filtering the digital signal with or without knowledge of the carriers RF or modulation parameters, (c) performing decimation and re-sampling of the digital signal and (d) performing blind equalization and demodulation thereby forming an error vector that is representative of the interference.
Patent NZ-534231-A (NZ)
Title: Use of acylaminoalkenylene-amide derivatives in treatment of functional motility disorders of the viscera
Inventor: FOZARD JOHN R
IPC: A61K31/55
Filed: 2003-02-07
Abstract: Disclosed herein is a use of acylaminoalkenylene-amide derivative compounds of formula (I) in free form or in the form of a pharmaceutically acceptable salt for the preparation of a medicament for the treatment of a functional motility disorder of the viscera, wherein the variables shown in formula (I) are as defined in the specification. These functional motility disorders are associated with visceral hypersenstivity and/or altered motor responses and include a functional bowel disorder or functional gastrointestinal disorder such as irritable bowel syndrome or functional dyspepsia.
Patent NZ-538075-A (NZ)
Title: 22.5 kD Streptococcus uberis protein or immunogenic fragment thereof mixed an additional antigen that is pathogenic to cows in a vaccine to treat bovine mastitis
Inventor: HENSEN SELMA MARIANNE
IPC: C12Q1/68
Filed: 2003-08-06
Abstract: A nucleic acid sequence (SEQ ID No:1) that encodes a 22.5 kD Streptococcus uberis protein. Parts of the sequence also encode immunogenic fragments of the protein, DNA fragments, recombinant DNA molecules, live recombinant carriers and ex-vivo host cells. Also disclosed is the use of the sequence for vaccines and the manufacture of vaccines, for protein and antibodies for diagnostic or vaccination and for diagnostic kits against the Streptococcus uberis protein.
Patent NZ-539083-A (NZ)
Title: Orthopoxvirus virus vector, such as vaccina, in which the A46R protein from vaccinia, is not expressed or is expressed but is non-functional
Inventor: O'NEILL LUKE ANTHONY JOHN
IPC: C07K14/07
Filed: 2003-09-29
Abstract: An orthopoxvirus, such as vaccinia, is described in which the A46R protein from vaccinia, is not expressed or is expressed but is non-functional. Also disclosed is the use of a vaccinia virus A46R protein in the modulation and/or inhibition of ILR/TR superfamily signalling.
Patent NZ-549379-A (NZ)
Title: Receptacle for sensor inserted in a gas stream
Inventor: BORALI STEFANO
Filed: 2004-02-23
Abstract: A receptacle for sensors (7) is insertable in a gas stream, houses at least one sensor (7) for controlling at least one physical/chemical parameter of the gas stream, and is defined by at least one boundary wall (8, 9), at least part of which is defined by a filtering element (17) permeable solely to the gaseous phase of the gas stream.
Patent NZ-563292-A (NZ)
Title: Evaluating drug data sets against aggregate sets from multiple institutions
Inventor: HOAG ROBERT E
IPC: G16H70/40
Filed: 2006-05-11
Abstract: A system and method for evaluating drug data sets is disclosed. The system and method includes identifying when entries in a current data set differ from a data set comprising an aggregate of entries for a plurality of institutions, and prompting a user to determine if a change in the current data set should be changed. The system and method also identifies cases where different dose units are used for the same drug. A report is generated noting exceptions.
Patent NZ-570503-A (NZ)
Title: Azacyclyl-substituted aryldihydroisoquinolinones, process for their preparation and their use as medicaments
Inventor: SCHWINK LOTHAR
IPC: C07D498/10
Filed: 2007-02-13
Abstract: Disclosed are compound represented by the general formula I which modulate the activity of MCH receptors and are notable for an antagonism of the MCH1R, in which the meanings are: R1, R1', R1'', R1''' independently of one another are H, F, Cl, Br, I, OH, CF3, NO2, CN, OCF3, O-alkyl, O-alkoxy-alkyl, S-alkyl, alkyl, alkenyl, cycloalkyl, O-cycloalkyl, cycloalkenyl, alkynyl, alkylene-aryl, O-alkylenearyl, S-aryl, N(R3)(R4), SO2-CH3, COOH, COO-alkyl, CON(R5)(R6), N(R7)CO(R8), N(R9)SO2(R10), CO(R11) or (C(R12)(R13))x-O(R14); Y is C(R27)(R27')C(R28)(R28') or C(R29)=C(R29'); X is S, O or C(R30)=C(R30'); A is a bond or a linker having 1 to 8 members; B is H, N(R35)(R36), hydroxy-alkyl, alkyl, alkoxy-alkyl, alkenyl, alkynyl or a 3 to 10-membered mono-, bi-, tri- or spirocyclic ring which may comprise 0 to 4 heteroatoms selected from the group of oxygen, nitrogen and sulphur, where the ring system may additionally be substituted; Q is a mono-, bi-, tri- or spirocyclic saturated or partly unsaturated ring structure having one nitrogen atom and 0-3 further heteroatoms; and wherein the remaining substituents are as defined herein. Also disclosed is the use of a compound as defined above in the manufacture of a medicament for the treatment and/or prevention of disorders of fatty acid metabolism, glucose utilization disorders, disorders in which insulin resistance is involved, diabetes mellitus and the squelae associated therewith, dyslipidemias and the squelae thereof and conditions associated with the metabolic syndrome.
Patent NZ-571018-A (NZ)
Title: Biological load indicator and method of measuring biological load
Inventor: SEKIYAMA ATSUO
IPC: G01N33/53
Filed: 2007-02-16
Abstract: Provided is the use of an test agent in testing various stress-related mental conditions by a logistic regression analysis, said test agent comprising at least three kinds of molecules selected from the group consisting of antibodies specifically recognizing Eotaxin, FGF basic, G-CSF, GM-CSF, IP- 10, MCP-1, MIP-1á, MIP-1â, PDGF-BB, RANTES, CSF-2, neurotrophin 15 5, MCP-3, â-2-microglobulin, angiotensin II, CSF-3, HGF, VEGF, TGF- â, IL-3, IL-5, IL-7, IL-9, IL-10, IL-11, IL-12, IL-13, IL-15, IL-17, IFN-g, IFN-a, CXC chemokine ligand 5, IL-4, IL-8, IL-2, TNF-a, CXC chemokine ligand 1, IL-1b and IL-1ra. The level of the markers can be determined from plasma, serum, saliva or urine.
Patent NZ-573721-A (NZ)
Title: Wine aerating pourer
Inventor: CHIORAZZI FRANK O
IPC: B01F23/00
Filed: 2008-12-18
Abstract: A wine aerator 100 includes (the figure illustrates a cross-section) a top funnel portion 10 into which the wine from the bottle can be poured, a constricted tube section 20 through which the wine will flow from the funnel portion and a bottom discharge section 50. As the wine flows through the constricted tube section 20, air is drawn by venturi action through the tubes 40 and mixed with the wine at a mixing zone 45 so that the aerated wine flows out of the discharge 50 into the glass. The air tubes slant upwards from the mixing zone so that wine doesn't tend to run along the tubes, a baffle 30 inhibits the formation of a vortex within the mixing zone, and the mixing zone near the top of the discharge portion may have a circumferential discontinuity to assist mixing of the air in the wine. Of course, liquids and fluids other than air and wine might be mixed in the aerator.
Patent NZ-574885-A (NZ)
Title: Transdermal application of triazines for controlling coccidia infections
Inventor: HEEP IRIS
IPC: A61K31/53
Filed: 2007-08-08
Abstract: Disclosed herein is the use of triazines of formula (I) or (II) wherein R1 represents R3-SO2- or R3-S-; R2 represents alkyl, alkoxy, halogen or SO2N(CH3)2; R3 represents haloalklyl; R4 and R5 independently of one another represent hydrogen or Cl and R6 represents fluorine or chlorine, for the preparation of compositions for the transdermal treatment of infections of animals or humans with coccidian, where the active substance of the formula (I) or (II) for transdermal application is used in a dose which is no more than 150% of the corresponding oral dosage rate under otherwise identical conditions.